바이오 분석 검사 서비스 시장 규모, 점유율, 성장 분석 : 분자별, 검사별, 워크플로우별, 용도별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)

Bioanalytical Testing Services Market size was valued at USD 3.6 Billion in 2023 and is poised to grow from USD 4.18 Billion in 2024 to USD 13.9 Billion by 2032, growing at a CAGR of 16.2% during the forecast period (2025-2032).

The global bioanalytical testing services market encompasses analytical services provided to pharmaceutical, biopharmaceutical, and biotechnology industries to support drug development and research. These services involve analyzing biological samples-such as blood, urine, and tissues-to determine drug concentrations, metabolites, and biomarkers, thereby assessing drug safety, efficacy, and pharmacokinetics. Contract research organizations (CROs) and specialized service providers play a pivotal role in delivering these essential services. A primary objective of the bioanalytical testing services market is to furnish reliable and accurate testing to facilitate the introduction of safe and effective drugs into the market. However, several challenges impede market growth. Notably, the high costs associated with bioanalytical testing services can be prohibitive, particularly for smaller pharmaceutical companies and research institutions. Additionally, the complexity and technical difficulties inherent in bioanalytical testing can limit the efficiency and accuracy of results, leading to extended turnaround times and potential data interpretation issues. Moreover, the lack of standardization in analytical methods and procedures poses significant challenges. Variations in methodologies can lead to inconsistencies in data, complicating the comparison and validation of results across different studies and laboratories. This lack of uniformity can hinder the drug development process and delay regulatory approvals. Addressing these challenges necessitates concerted efforts to standardize analytical methods, invest in advanced technologies to streamline processes, and implement cost-effective strategies. Such measures are vital to overcoming existing barriers and fostering growth within the bioanalytical testing services market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioanalytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioanalytical Testing Services Market Segments Analysis

Global Bioanalytical Testing Services Market is segmented by Molecule, Test, Workflow, Application, End Use and region. Based on Molecule, the market is segmented into Small Molecule, Large Molecule and Others. Based on Test, the market is segmented into ADME, PK, PD, Bioavailability, Bioequivalence and Others. Based on Workflow, the market is segmented into Sample Preparation, Sample Analysis and Other Workflow Processes. Based on Application, the market is segmented into Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology and Other Applications. Based on End Use, the market is segmented into Pharma & BioPharma Companies, CDMO and CRO. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bioanalytical Testing Services Market

The escalating number of pharmaceutical trials and the intensified focus on developing new drugs and biopharmaceuticals are significantly boosting the demand for bioanalytical testing services. These services are crucial for ensuring the accuracy and reliability of data, which in turn guarantees the efficacy and safety of pharmaceutical products. As pharmaceutical companies invest more in research and development, there is a corresponding increase in the need for comprehensive bioanalytical testing to support drug development and regulatory approval processes.

Restraints in the Bioanalytical Testing Services Market

The substantial expenses associated with bioanalytical testing, particularly for advanced specialized analyses, can pose significant challenges for smaller pharmaceutical companies and research institutions. These high costs often serve as barriers, potentially hindering the progression of drug development projects within these organizations.

Market Trends of the Bioanalytical Testing Services Market

The integration of biomarker discovery into bioanalytical testing projects is gaining momentum, reflecting its critical role in personalized medicine, early diagnosis, and targeted therapies. Biomarkers-biological molecules measurable in blood, tissues, or other fluids-provide insights into normal or pathological processes and treatment responses. Their identification and validation are essential for diagnosing diseases, predicting outcomes, and tailoring treatments. Advanced technologies, such as mass spectrometry, genomics, and proteomics, facilitate the precise detection and quantification of these biomarkers. By leveraging these cutting-edge tools, bioanalytical testing services enhance the development of novel treatments and diagnostic tools, thereby advancing precision medicine and improving patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Bioanalytical Testing Services Market Size by Molecule & CAGR (2025-2032)

• Market Overview
• Small Molecule
• Large Molecule
  • LC-MS Studies
  • Immunoassays
  • PK
  • ADA
  • Others
• Others

Global Bioanalytical Testing Services Market Size by Test & CAGR (2025-2032)

• Market Overview
• ADME
  • In-Vivo
  • In-Vitro
• PK
• PD
• Bioavailability
• Bioequivalence
• Others

Global Bioanalytical Testing Services Market Size by Workflow & CAGR (2025-2032)

• Market Overview
• Sample Preparation
  • Protein Precipitation
  • Liquid-Liquid Extraction
  • Solid Phase Extraction
• Sample Analysis
  • Hyphenated technique
  • Chromatographic technique
  • Electrophoresis
  • Ligand Binding Assay
  • Mass Spectrometry
  • Nuclear Magnetic Resonance
• Other Workflow Processes

Global Bioanalytical Testing Services Market Size by Application & CAGR (2025-2032)

• Market Overview
• Oncology
• Neurology
• Infectious Diseases
• Gastroenterology
• Cardiology
• Other Applications

Global Bioanalytical Testing Services Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Pharma & BioPharma Companies
• CDMO
• CRO

Global Bioanalytical Testing Services Market Size & CAGR (2025-2032)

• North America (Molecule, Test, Workflow, Application, End Use)
  • US
  • Canada
• Europe (Molecule, Test, Workflow, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Molecule, Test, Workflow, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Molecule, Test, Workflow, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Molecule, Test, Workflow, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcorp Drug Development (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Q2 Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intertek Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACM Global Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Frontage Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAgilytix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KCAS Bioanalysis & Biomarker Services (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific BioLabs (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations